Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Endometrial Neoplasms 7Lymphatic Metastasis 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 3Breast Neoplasms 3Thyroid Cancer, Papillary 2Stomach Neoplasms 2Prostatic Neoplasms 2Postoperative Complications 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphedema 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Carcinoma, Transitional Cell 2Vulvar Neoplasms 1Uterine Neoplasms 1Urologic Neoplasms 1Ureteral Neoplasms 1Thyroid cancer, follicular 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Recurrence 1Radiation Injuries 1Prostate Adenocarcinoma 1Platelet Glycoprotein IV Deficiency 1Parotid Neoplasms 1

Interventions

Gemcitabine 61Cisplatin 39Oxaliplatin 31Capecitabine 29Fluorouracil 22Leucovorin 20Irinotecan 12pembrolizumab 11130-nm albumin-bound paclitaxel 10durvalumab 9Erlotinib Hydrochloride 8Trastuzumab 7Bevacizumab 7Taxes 6Platinum 6Magnetic Resonance Spectroscopy 6Biopsy 6Albumin-Bound Paclitaxel 61,2-diaminocyclohexaneplatinum II citrate 6Specimen Handling 5Sorafenib 5Radiotherapy 5Docetaxel 5Carboplatin 5Immunohistochemistry 4trifluridine tipiracil drug combination 3dehydroftorafur 3atezolizumab 3Watchful Waiting 3Tegafur 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gallbladder Neoplasms × Lymph Node Excision × Clear all
NCT04559139 2026-05-01

Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

Eastern Cooperative Oncology Group

Phase 2/3 Active not recruiting
186 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡